Companion diagnostic co-development has the potential to significantly alter the drug development process and commercialization of drug candidates by yielding safer drugs with enhanced therapeutic efficacy in a faster, more cost-effective manner. This can be done by providing drug developers information on how a drug works in the body, before clinical signs and symptoms are evaluated in patients through trials."


There was a post today showing how Lympro will not only save about 2,500 dollars per time it is used, but also speed up clinical and drug designations for future use. A keen eye need not read more than the first paragraph to notice to striking similarities. Boom.